ペット糖尿病ケア市場レポート：ソリューション、動物タイプ、流通チャネル、地域別、2024-2032

世界のペット糖尿病ケア市場規模は2023年に20億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに37億米ドルに達し、2024年から2032年の間に6.77%の成長率（CAGR）を示すと予測しています。ペットの肥満の増加、ペットの人間化傾向の台頭、主要企業による広範な研究開発（R&D）活動、消費者の支出能力の上昇が、市場を推進している主な要因の一部です。

ペット糖尿病ケアは、犬や猫の糖尿病の診断、治療、管理を扱う獣医学の専門分野を指します。糖尿病は、血糖値を適切に調節できない体質を特徴とする慢性疾患です。ペット糖尿病ケアには、血糖値の定期的なモニタリング、インスリン投与、食事管理、ペットのライフスタイルの改善など、さまざまな側面が含まれます。この分野の訓練を受けた獣医師や獣医の専門家は、飼い主と緊密に連携して個別の治療計画を立て、病気について教育し、継続的なサポートを提供します。ペットの糖尿病治療の目標は、ペットの生活の質を最適化し、糖尿病に伴う健康合併症を予防し、医学的介入、食事管理、生活習慣の改善を組み合わせて効率的な血糖コントロールを達成することです。

座りがちなライフスタイル、肥満、遺伝的素因、ペットの高齢化などにより、ペットの糖尿病有病率が上昇していることが、予測期間中の市場の成長を刺激します。さらに、ペットの人間化という新たな動向と、コンパニオンアニマルに最適なヘルスケアを提供したいというペットオーナーの願望の高まりが、ペットオーナーの間で製品採用率を加速させています。ペットの飼い主は、ペットが適切かつタイムリーなケアを受けられるように、定期的な獣医の診察、糖尿病管理ツール、特殊な食事により多くの投資を行うことを望んでいます。これとは別に、改良されたインスリン製剤、グルコース・モニタリング・デバイス、遠隔モニタリングとコンサルテーションを容易にする遠隔医療ソリューションなど、ペットの糖尿病に利用可能な治療オプションの範囲の拡大を含む、獣医学と技術における多数の進歩が、市場の成長を促進しています。さらに、飼い主や獣医専門家の間でペットの糖尿病に対する認識や教育が高まっていることも、市場の成長に寄与しています。

ペット糖尿病ケアの市場動向と促進要因

ペットの肥満率の増加

ペットの肥満率の上昇は、ペット用糖尿病ケアソリューションの需要を促進する主な要因です。より多くのペットが太りすぎや肥満になるにつれ、糖尿病を発症するリスクが高くなっています。ペットの飼い主は、糖尿病の可能性が高くなるなど、ペットの肥満に伴う健康リスクへの認識が高まっているため、こうした状態に対処し、予防するためのソリューションを求めています。その結果、ペットが健康的な体重を維持し、糖尿病や関連疾患の発症リスクを軽減できるよう設計された体重管理プログラム、特殊な食事療法、運動療法に対する需要が高まっています。このほか、ペットの肥満対策への関心の高まりは、ペットの飼い主が効果的な体重管理戦略を通じて糖尿病を予防・管理できるよう支援することを目的とした、ペット糖尿病ケアに関する新製品やサービスの開発を促しています。

ペットの健康とウェルネスへの関心の高まり

ペットの健康とウェルネスへの注目の高まりも市場の主要促進要因です。ペットの飼い主は、ペットの全体的な健康を確保するために多額の投資を行っており、予防ヘルスケアソリューションや糖尿病のような慢性疾患の包括的な管理を求めています。飼い主はペットの健康をより積極的に監視するようになり、定期的に獣医の検診を受け、潜在的な健康問題により警戒するようになっています。このような飼い主の考え方の大きな変化により、血糖値の定期的なモニタリング、インスリン投与、食事管理など、ペット専門の糖尿病ケアに対する需要が高まっています。市場は、高度な血糖値モニタリング・システム、インスリン・ペン、糖尿病専用ペットフード製剤などの革新的な製品やサービスを提供することで、この動向に対応しています。ペットの飼い主はまた、ペットの糖尿病管理に関する情報やリソースを積極的に求めており、このトピックに関する認識や教育の急増につながっています。

獣医療と技術の進歩

獣医学と技術における絶え間ない進歩は、ペットの糖尿病管理を大幅に改善し、市場に前向きな変化をもたらしています。これらの進歩には、より正確で使いやすいグルコース・モニタリング・システムの開発が含まれ、これにより飼い主はペットの血糖値を便利かつ正確にモニターできるようになった。さらに、遠隔医療と遠隔モニタリング・ツールの統合により、ペットの飼い主が頻繁に訪問することなく、獣医の専門家から指導やサポートを受けることができるため、より便利で効率的な糖尿病管理が可能になった。さらに、電子カルテとデータ解析の利用が増えたことで、糖尿病のペットの全体的な管理と治療成績が向上しています。獣医学とテクノロジーにおけるこれらの革新は、ペットの病気を管理するためのより良いツールとリソースを飼い主に提供し、糖尿病のペットの全体的なケアと生活の質を向上させています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査目的
• 利害関係者
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要産業動向

第5章 世界のペット糖尿病ケア市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：ソリューション別

• トリートメント
  • 市場動向
  • 市場予測
• グルコースモニタリングデバイス
  • 市場動向
  • 市場予測

第7章 市場内訳：動物タイプ別

• 犬
  • 市場動向
  • 市場予測
• 猫
  • 市場動向
  • 市場予測

第8章 市場内訳：流通チャネル別

• 動物病院・クリニック
  • 市場動向
  • 市場予測
• 小売薬局
  • 市場動向
  • 市場予測
• オンラインストア
  • 市場動向
  • 市場予測

第9章 市場内訳：地域別

• 北米
  • 米国
    • 市場動向
    • 市場予測
  • カナダ
    • 市場動向
    • 市場予測
• アジア太平洋
  • 中国
    • 市場動向
    • 市場予測
  • 日本
    • 市場動向
    • 市場予測
  • インド
    • 市場動向
    • 市場予測
  • 韓国
    • 市場動向
    • 市場予測
  • オーストラリア
    • 市場動向
    • 市場予測
  • インドネシア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測
• 欧州
  • ドイツ
    • 市場動向
    • 市場予測
  • フランス
    • 市場動向
    • 市場予測
  • 英国
    • 市場動向
    • 市場予測
  • イタリア
    • 市場動向
    • 市場予測
  • スペイン
    • 市場動向
    • 市場予測
  • ロシア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測
• ラテンアメリカ
  • ブラジル
    • 市場動向
    • 市場予測
  • メキシコ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測
• 中東・アフリカ地域
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • ACON Laboratories Inc.
  • Allison Medical Inc.
  • Becton Dickinson and Company
  • Boehringer Ingelheim International GmbH
  • i-SENS Inc.
  • Merck & Co. Inc.
  • Trividia Health Inc.（Sinocare）
  • UltiMed Inc.
  • Zoetis Inc.

List of Figures

• Figure 1: Global: Pet Diabetes Care Market: Major Drivers and Challenges
• Figure 2: Global: Pet Diabetes Care Market: Sales Value (in Billion US$), 2018-2023
• Figure 3: Global: Pet Diabetes Care Market Forecast: Sales Value (in Billion US$), 2024-2032
• Figure 4: Global: Pet Diabetes Care Market: Breakup by Solution (in %), 2023
• Figure 5: Global: Pet Diabetes Care Market: Breakup by Animal Type (in %), 2023
• Figure 6: Global: Pet Diabetes Care Market: Breakup by Distribution Channel (in %), 2023
• Figure 7: Global: Pet Diabetes Care Market: Breakup by Region (in %), 2023
• Figure 8: Global: Pet Diabetes Care (Treatment) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 9: Global: Pet Diabetes Care (Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 10: Global: Pet Diabetes Care (Glucose Monitoring Devices) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 11: Global: Pet Diabetes Care (Glucose Monitoring Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 12: Global: Pet Diabetes Care (Dogs) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 13: Global: Pet Diabetes Care (Dogs) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 14: Global: Pet Diabetes Care (Cats) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 15: Global: Pet Diabetes Care (Cats) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 16: Global: Pet Diabetes Care (Veterinary Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 17: Global: Pet Diabetes Care (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 18: Global: Pet Diabetes Care (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 19: Global: Pet Diabetes Care (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 20: Global: Pet Diabetes Care (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
• Figure 21: Global: Pet Diabetes Care (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 22: North America: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 23: North America: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 24: United States: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 25: United States: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 26: Canada: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 27: Canada: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 28: Asia-Pacific: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 29: Asia-Pacific: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 30: China: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 31: China: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 32: Japan: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 33: Japan: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 34: India: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 35: India: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 36: South Korea: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 37: South Korea: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 38: Australia: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 39: Australia: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 40: Indonesia: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 41: Indonesia: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 42: Others: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 43: Others: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 44: Europe: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 45: Europe: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 46: Germany: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 47: Germany: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 48: France: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 49: France: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 50: United Kingdom: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 51: United Kingdom: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 52: Italy: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 53: Italy: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 54: Spain: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 55: Spain: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 56: Russia: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 57: Russia: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 58: Others: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 59: Others: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 60: Latin America: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 61: Latin America: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 62: Brazil: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 63: Brazil: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 64: Mexico: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 65: Mexico: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 66: Others: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 67: Others: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 68: Middle East and Africa: Pet Diabetes Care Market: Sales Value (in Million US$), 2018 & 2023
• Figure 69: Middle East and Africa: Pet Diabetes Care Market: Breakup by Country (in %), 2023
• Figure 70: Middle East and Africa: Pet Diabetes Care Market Forecast: Sales Value (in Million US$), 2024-2032
• Figure 71: Global: Pet Diabetes Care Industry: SWOT Analysis
• Figure 72: Global: Pet Diabetes Care Industry: Value Chain Analysis
• Figure 73: Global: Pet Diabetes Care Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Pet Diabetes Care Market: Key Industry Highlights, 2023 and 2032
• Table 2: Global: Pet Diabetes Care Market Forecast: Breakup by Solution (in Million US$), 2024-2032
• Table 3: Global: Pet Diabetes Care Market Forecast: Breakup by Animal Type (in Million US$), 2024-2032
• Table 4: Global: Pet Diabetes Care Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
• Table 5: Global: Pet Diabetes Care Market Forecast: Breakup by Region (in Million US$), 2024-2032
• Table 6: Global: Pet Diabetes Care Market: Competitive Structure
• Table 7: Global: Pet Diabetes Care Market: Key Players

The global pet diabetes care market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.77% during 2024-2032. The increasing prevalence of obesity in pets, the emerging pet humanization trend, extensive research and development (R&D) activities by key players, and rising expenditure capacities of consumers are some of the major factors propelling the market.

Pet diabetes care refers to the specialized field of veterinary medicine that deals with the diagnosis, treatment, and management of diabetes in dogs and cats. It involves comprehensive care and support for pets with diabetes mellitus, a chronic condition characterized by the body's inability to properly regulate blood sugar levels. Pet diabetes care encompasses various aspects, including the regular monitoring of blood glucose levels, insulin administration, dietary management, and lifestyle modifications of pets. Veterinarians and veterinary professionals trained in this field work closely with pet owners to create individualized treatment plans, educate them about the disease, and provide ongoing support. The goal of pet diabetes care is to optimize the pet's quality of life, prevent health complications associated with diabetes, and achieve efficient glycemic control through a combination of medical intervention, dietary management, and lifestyle modifications.

The rising prevalence of diabetes in pets due to sedentary lifestyles, obesity, genetic predisposition, and an aging pet population will stimulate the growth of the market during the forecast period. Moreover, the emerging trend of pet humanization and the growing desire of pet owners to provide optimal healthcare for companion animals have accelerated the product adoption rate among pet owners. Pet owners are willing to invest more in regular veterinary visits, diabetes management tools, and specialized diets to ensure that their pets receive proper and timely care. Apart from this, numerous advancements in veterinary medicine and technology, including the expansion of the range of treatment options available for pet diabetes such as improved insulin formulations, glucose monitoring devices, and telemedicine solutions that facilitate remote monitoring and consultation is propelling the market growth. Furthermore, the heightening awareness and education about pet diabetes among owners and veterinary professionals is contributing to the market growth.

Pet Diabetes Care Market Trends/Drivers:

Increase in pet obesity rates

The rising prevalence of obesity among pets is a major factor driving the demand for pet diabetes care solutions. As more and more pets become overweight or obese, they are at a higher risk of developing diabetes. Pet owners are becoming increasingly aware of the health risks associated with obesity in their pets, including the higher likelihood of diabetes, and are therefore seeking solutions to address and prevent these conditions. This in turn has led to a growing demand for weight management programs, specialized diets, and exercise regimens designed to help pets maintain a healthy weight and reduce the risk of developing diabetes and associated conditions. Besides this, the increasing focus on combating pet obesity is encouraging the development of new products and services related to pet diabetes care, aimed at helping pet owners prevent and manage diabetes through effective weight management strategies.

Growing focus on pet health and wellness

The growing focus on pet health and wellness is another major driver in the market. Pet owners are heavily investing in ensuring the overall well-being of their pets and are seeking preventive healthcare solutions and comprehensive management of chronic conditions like diabetes. They have become more proactive in monitoring their pets' health, are going for regular veterinary check-ups and being more vigilant about potential health issues. This substantial shift in pet owners' mindset has strengthened the demand for specialized pet diabetes care, including regular monitoring of blood glucose levels, insulin administration, and dietary management. The market is responding to this trend by offering innovative products and services such as advanced glucose monitoring systems, insulin pens, and specialized diabetic pet food formulations. Pet owners are also actively seeking information and resources on managing diabetes in pets, leading to a surge in awareness and education on the topic.

Advancements in veterinary medicine and technology

Constant advancements in veterinary medicine and technology have significantly improved the management of diabetes in pets and are driving positive changes in the market. These advancements include the development of more accurate and user-friendly glucose monitoring systems, which enable pet owners to monitor their pets' blood sugar levels conveniently and accurately. Additionally, the integration of telemedicine and remote monitoring tools has enabled more convenient and efficient diabetes management, as pet owners can receive guidance and support from veterinary professionals without the need for frequent in-person visits. Furthermore, the increasing use of electronic health records and data analytics has improved the overall management and treatment outcomes of pets with diabetes. These innovations in veterinary medicine and technology are providing pet owners with better tools and resources for managing the disease in their pets, enhancing the overall care and quality of life for diabetic pets.

Pet Diabetes Care Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global pet diabetes care market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on solution, animal type and distribution channel.

Breakup by Solution:

Treatment

Glucose Monitoring Devices

Treatment represents the most popular solution

The report has provided a detailed breakup and analysis of the market based on the solution. This includes treatment, and glucose monitoring devices. According to the report, treatment represented the largest segment.

Treatment plays a crucial role in driving the market growth as it encompasses a range of interventions and therapies aimed at managing diabetes in pets. Effective treatment options are essential to provide optimal care and improve the quality of life for pets with diabetes. Treatment fuels the market growth by creating a consistent and steady demand for various products and services, such as insulin formulations, glucose monitoring systems, specialized diabetic pet food, and veterinary consultations.

Furthermore, the easy availability of diverse treatment options allows pet owners and veterinary professionals to tailor the management approach to the individual needs of each pet, which in turn is propelling the market growth. Moreover, ongoing advancements in treatment options, including improved insulin formulations and delivery methods, advanced glucose monitoring technologies, and personalized nutrition, further contribute to the growth of the market.

Breakup by Animal Type:

Dogs

Cats

Dogs dominate the market

A detailed breakup and analysis of the market based on the animal type has also been provided in the report. This includes dogs and cats. According to the report, dogs accounted for the largest market share.

Dogs play a significant role in propelling the market due to their high prevalence of diabetes and the growing awareness of this condition among dog owners. Dogs are more susceptible to developing diabetes compared to other pets, and as a result, there is a greater demand for specialized care and management options for diabetic dogs. The increasing prevalence of obesity in dogs, which is a major risk factor for diabetes, further contributes to the need for pet diabetes care solutions for dogs.

Furthermore, dog owners are becoming more educated about the symptoms, diagnosis, and treatment of diabetes in dogs, leading to more frequent veterinary visits and the adoption of appropriate disease management strategies. This growing awareness drives the development and availability of specific products and services tailored to diabetic dogs, including glucose monitoring devices, insulin formulations, diabetic dog food, and educational resources. The unique role of dogs in the market for pet diabetes care underscores the importance of addressing their specific needs and fueling advancements in diabetes management for this companion animal.

Breakup by Distribution Channel:

Veterinary Hospitals and Clinics

Retail Pharmacies

Online Stores

Veterinary hospitals and clinics hold the largest share in the market

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes veterinary hospitals and clinics, retail pharmacies, and online stores. According to the report, veterinary hospitals and clinics represented the largest segment.

Veterinary hospitals and clinics are the primary providers of specialized care and treatment for pets with diabetes. These healthcare facilities serve as the central hub for diagnosing, monitoring, and managing diabetes in pets. Veterinary hospitals and clinics offer crucial services such as blood glucose monitoring, insulin administration, dietary counseling, and regular check-ups to ensure effective diabetes management in pets. They play a vital role in educating pet owners about the importance of diabetes care, including the need for regular veterinary visits, adherence to treatment plans, and lifestyle modifications. Furthermore, these healthcare facilities often stock and dispense diabetes-related products such as insulin, glucose monitoring devices, and specialized diabetic pet food, contributing to the widespread availability and accessibility of these essential supplies. Veterinary hospitals and clinics are at the forefront of research and advancements in pet diabetes care, driving innovations and improving treatment options. Their expertise and guidance are crucial in improving the quality of life of pets with diabetes and fostering the growth of the market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for pet diabetes care.

North America held the biggest share in the market since the region has a high pet ownership rate and a strong culture of pet care, resulting in a large market for pet healthcare products and services, including diabetes care. The rising awareness and understanding of pet diabetes among pet owners in North America contributes to the high demand for specialized care and treatment options. Veterinary clinics and hospitals in the North America region are at the forefront of research, innovation, and advancements in pet diabetes management, fostering the development of new products and treatment protocols.

Additionally, North America has a well-established veterinary healthcare infrastructure with an extensive network of veterinary professionals and specialized pet care facilities, ensuring easy accessibility to pet diabetes care. The large presence of leading pharmaceutical and healthcare companies in the region further supports the growth of the market in North America through the development and distribution of diabetes management products, including insulin, glucose monitoring devices, and specialized pet food.

Competitive Landscape:

The market is experiencing a lower-than-anticipated demand compared to pre-pandemic levels. However, this is likely to witness a paradigm shift over the next decade with the development of advanced glucose monitoring systems specifically designed for pets. Moreover, there have been advancements in insulin formulations and delivery methods, offering improved options for insulin administration and absorption. Key players are also introducing long-acting insulin formulations that provide more stable blood glucose control and reduce the frequency of injections. Additionally, the leading manufacturers are integrating telemedicine and remote monitoring technologies, enabling pet owners to consult with veterinary professionals and receive guidance on diabetes management from the comfort of their homes. We also expect the market to witness new entrants, consolidation of product portfolios, increased research-related efforts by key players, and a rise in strategic collaborations to drive healthy competition within the domain.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

ACON Laboratories Inc.

Allison Medical Inc.

Becton Dickinson and Company

Boehringer Ingelheim International GmbH

i-SENS Inc.

Merck & Co. Inc.

Trividia Health Inc. (Sinocare)

UltiMed Inc.

Zoetis Inc.

Recent Developments:

In August 2020, Boehringer Ingelheim International GmbH launched the 20 ml presentation of Prozinc (protamine zinc recombinant human insulin) as a single-dose daily drug for canines associated with diabetes. This new presentation offers pet owners a convenient and precise option for administering insulin to their diabetic dogs, simplifying the management of the condition. The company's introduction of the 20 ml Prozinc presentation demonstrates their commitment to improving the treatment options available for diabetic dogs and addressing the needs of pet owners and veterinarians in managing canine diabetes effectively.

In August 2019, Zoetis, a leading animal health company, stated that its Diabetes Pet Care Alliance program was receiving continuous support from partner companies such as Merck Animal Health and Purina. The Diabetes Pet Care Alliance program focuses on raising awareness about diabetes in pets, providing educational resources for pet owners and veterinary professionals, and promoting the management of diabetes in pets through proper care, nutrition, and treatment. The ongoing support from partner companies demonstrates their shared commitment to improving the well-being and quality of life for pets living with diabetes.

Key Questions Answered in This Report

• 1. How big is the global pet diabetes care market?
• 2. What is the expected growth rate of the global pet diabetes care market during 2024-2032?
• 3. What are the key factors driving the global pet diabetes care market?
• 4. What has been the impact of COVID-19 on the global pet diabetes care market?
• 5. What is the breakup of the global pet diabetes care market based on solution?
• 6. What is the breakup of the global pet diabetes care market based on the animal type?
• 7. What is the breakup of the global pet diabetes care market based on the distribution channel?
• 8. What are the key regions in the global pet diabetes care market?
• 9. Who are the key players/companies in the global pet diabetes care market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Pet Diabetes Care Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Solution

• 6.1 Treatment
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Glucose Monitoring Devices
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Animal Type

• 7.1 Dogs
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Cats
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Veterinary Hospitals and Clinics
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Retail Pharmacies
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Online Stores
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 ACON Laboratories Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Allison Medical Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Becton Dickinson and Company
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Boehringer Ingelheim International GmbH
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 i-SENS Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
  • 14.3.6 Merck & Co. Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Trividia Health Inc. (Sinocare)
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 UltiMed Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Zoetis Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis